Announcements Trials
Browse Landscape

Status

Completed 3Unknown 2

Sponsor Class

INDUSTRY 5

Study Type

Observational 5Interventional 3

Sponsor

Conditions

Breast Neoplasms 2929Neoplasms 2624Lung Neoplasms 1366Colorectal Neoplasms 1328Prostatic Neoplasms 1214Carcinoma, Non-Small-Cell Lung 1079Carcinoma, Hepatocellular 782Stomach Neoplasms 720Pancreatic Neoplasms 701Ovarian Neoplasms 586Colonic Neoplasms 533Uterine Cervical Neoplasms 497Head and Neck Neoplasms 495Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 422Neoplasm Metastasis 418Brain Neoplasms 404Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 397Urinary Bladder Neoplasms 386Leukemia, Myeloid, Acute 385Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 312Recurrence 298Disease 272

Interventions

Fentanyl 3Nasal Sprays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Breakthrough Cancer Pain × Clear all
NCT03895762 2022-05-05

OASIS

A.Menarini Asia-Pacific Holdings Pte Ltd

Completed
143 enrolled

Breakthrough Cancer Pain

NCT02899884 2019-11-22

Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain

Takeda

Completed
3,765 enrolled 10 charts

Breakthrough Cancer Pain

NCT01693328 2014-01-15

Qualipec

Archimedes Development Ltd

Unknown
300 enrolled

Breakthrough Cancer Pain

NCT01698645 2013-07-11

Qualipec

Archimedes Development Ltd

Unknown
150 enrolled

Breakthrough Cancer Pain

NCT01045603 2012-10-29

INIS

Takeda

Completed
309 enrolled

Breakthrough Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡